Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This study evaluated the time to bacteriological eradication of common pathogens during
moxifloxacin therapy for acute bacterial maxillary sinusitis. The study also examined the
time to resolution of key symptoms associated with sinusitis.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination